TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
46,085
|
72,392
|
308,487 |
| Financial expenses |
669
|
1,548
|
751 |
| Earnings before taxes |
-442,674
|
-334,402
|
-40,204 |
| EBITDA |
-485,802
|
-374,763
|
-48,167 |
| Total assets |
1,020,197
|
1,418,427
|
1,619,605 |
| Current assets |
972,734
|
1,148,033
|
1,025,428 |
| Current liabilities |
98,186
|
76,907
|
82,596 |
| Equity capital |
913,539
|
1,326,795
|
1,519,251 |
| - share capital |
13,573
|
13,333
|
12,291 |
| Employees (average) |
112
|
104
|
89 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
89.5%
|
93.5%
|
93.8% |
| Turnover per employee |
411
|
696
|
3,466 |
| Profit as a percentage of turnover |
-960.6%
|
-461.9%
|
-13.0% |
| Return on assets (ROA) |
-43.3%
|
-23.5%
|
-2.4% |
| Current ratio |
990.7%
|
1492.8%
|
1241.5% |
| Return on equity (ROE) |
-48.5%
|
-25.2%
|
-2.6% |
| Change turnover |
-27,613
|
-257,984
|
290,151 |
| Change turnover % |
-37%
|
-78%
|
1582% |
| Chg. No. of employees |
8
|
15
|
10 |
| Chg. No. of employees % |
8%
|
17%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.